Individualizing Treatment for Asthma in Primary Care (Full Study)
NCT07052942
This study is recruiting at 8 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Asthma
- Asthma Attack
- Asthma Exacerbations
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 13 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- DARTNet Institute
- Last updated on ClinicalTrials.gov
- October 29, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 2
- DARTNet Institute · Aurora, CO
- University Colorado-Denver · Aurora, CO
Massachusetts · 1
- Reliant Medical Group · Worcester, MA
New Jersey · 1
- Rutgers Robert Wood Johnson Medical School · New Brunswick, NJ
New York · 1
- Mt. Sinai School of Medicine · New York, NY
North Carolina · 2
- University North Carolina · Chapel Hill, NC
- Atrium Health · Charlotte, NC
Texas · 1
- Kelsey Research Foundation · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.